Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Roche said on Friday that it has acquired Seattle-based early-stage sequencing technology firm Stratos Genomics for an undisclosed amount in a bid to advance development of Roche's nanopore sequencer.

Regeneron Pharmaceuticals and the Colorado Center for Personalized Medicine (CCPM) said Monday that they would sequence 450,000 exomes and match the results with phenotypic data from deidentified patient health records to advance drug discov

Quanterix said on Monday it has inked a non-exclusive agreement with Brigham and Women's Hospital for a SARS-CoV-2 serology test on its Simoa multiplex immunoassay platform.

People of different ancestral backgrounds can have different DNA methylation, mRNA, and microRNA expression levels, which in turn may affect how cancer manifests in patients from different populations and influence how it is treated, a new s

Castle Biosciences reported after the close of the market on Monday that it doubles its first quarter revenues year over year.

10x Genomics reported after the close of the market on Monday a 34 percent increase in first quarter revenues. For the three months ended March 31, the Pleasanton, California-based single-cell and spatial analysis technologies firm reported

Researchers have isolated a coronavirus from Malayan pangolins that is highly similar to SARS-CoV-2, suggesting pangolins may have served as an intermediate host for the virus.

Grifols Diagnostic Solutions announced Thursday its Procelix Panther System featuring Automation Ready Technology (ART) received approval from the US Food and Drug Administration.

Guardant Health reported after the close of the market on Thursday that its first quarter 2019 revenues were up 84 percent year over year.

Grail said today that it has raised $390 million in a Series D financing round, which included new investors Public Sector Pension Investment Board, Canada Pension Plan Investment Board, and two other undisclosed contributors.